195 related articles for article (PubMed ID: 1603565)
1. Oriental sore: a case report.
Asvesti C; Anastassiadis G; Kolokotronis A; Zographakis I
Oral Surg Oral Med Oral Pathol; 1992 Jan; 73(1):56-8. PubMed ID: 1603565
[TBL] [Abstract][Full Text] [Related]
2. Leishmaniasis of the lip.
Veraldi S; Rigoni C; Gianotti R
Acta Derm Venereol; 2002; 82(6):469-70. PubMed ID: 12575860
[No Abstract] [Full Text] [Related]
3. Case report: Leishmaniasis of the upper lip.
Veraldi S; Bottini S; Persico MC; Lunardon L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Nov; 104(5):659-61. PubMed ID: 17656118
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous lupoid leishmaniasis: a case report.
Ferahbaş A; Mistik S; Utaş S; Yaman O; Canoz O; Doganay M; Aşçioglu O
Cutis; 2006 Jan; 77(1):25-8; quiz 37-8. PubMed ID: 16475491
[TBL] [Abstract][Full Text] [Related]
5. A double-blind randomized clinical trial of a topical herbal extract (Z-he) vs. systemic meglumine antimonate.
Momeni AZ; Aminjavaheri M
Int J Dermatol; 2000 Nov; 39(11):880. PubMed ID: 11123462
[No Abstract] [Full Text] [Related]
6. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
[TBL] [Abstract][Full Text] [Related]
7. Intralesional injections of meglumine antimoniate to treat complex facial leishmania infantum acquired in Spain: a case report.
Mostmans Y; Van Gysel J; Vanden Nest H; Mervillie K; Richert B; Clevenbergh P
J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e548-e550. PubMed ID: 35181939
[No Abstract] [Full Text] [Related]
8. Old-world leishmaniasis of the auricle.
Skevas A; Kastanioudakis I; Bai M; Kostoula A
Lancet; 1997 Jan; 349(9044):28-9. PubMed ID: 8988123
[No Abstract] [Full Text] [Related]
9. [Infiltrated plaque on the lip].
Litaiem N; Jaber K; El Khalifa J; Kaabi W; Soumaya Y; Dhaoui MR; Doss N
Ann Dermatol Venereol; 2013; 140(8-9):547-8. PubMed ID: 24034642
[No Abstract] [Full Text] [Related]
10. Disseminated cutaneous leishmaniasis: a patient with 749 lesions.
Sousa AQ; Pompeu MM; Sólon FR; Frutuoso MS; Teixeira MJ; Silva TM
Braz J Infect Dis; 2006 Jun; 10(3):230. PubMed ID: 17568857
[No Abstract] [Full Text] [Related]
11. [Erysipeloid cutaneous leishmaniasis: about a clinical observation].
El kartouti A; Elbenaye J; Miloudi M
Pan Afr Med J; 2015; 21():54. PubMed ID: 26405490
[TBL] [Abstract][Full Text] [Related]
12. Use of meglumine antimoniate in canine leishmaniasis.
Lamothe J
Vet Rec; 2004 Mar; 154(12):378. PubMed ID: 15074332
[No Abstract] [Full Text] [Related]
13. Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis.
Vélez I; López L; Sánchez X; Mestra L; Rojas C; Rodríguez E
Am J Trop Med Hyg; 2010 Aug; 83(2):351-6. PubMed ID: 20682881
[TBL] [Abstract][Full Text] [Related]
14. Response of cutaneous leishmaniasis (chiclero's ulcer) to treatment with meglumine antimoniate in Southeast Mexico.
Vargas-Gonzalez A; Canto-Lara SB; Damian-Centeno AG; Andrade-Narvaez FJ
Am J Trop Med Hyg; 1999 Dec; 61(6):960-3. PubMed ID: 10674678
[TBL] [Abstract][Full Text] [Related]
15. Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
Teva A; Porrozzi R; Oliveira-Neto MP; Grimaldi GJ
J Parasitol; 2005 Aug; 91(4):976-8. PubMed ID: 17089782
[TBL] [Abstract][Full Text] [Related]
16. [N-methyl glucamine antimoniate or Glucantime].
Rapp C; Simon F; Dordain ML
Med Trop (Mars); 2000; 60(4):342-3. PubMed ID: 11436584
[No Abstract] [Full Text] [Related]
17. [Successful treatment of cutaneous leishmaniasis with amphotericin B; a case of unresponsive to pentavalent antimony therapy].
Yeşilova Y; Turan E; Sürücü HA; Aksoy M; Özbilgin A
Turkiye Parazitol Derg; 2015 Mar; 39(1):63-5. PubMed ID: 25917587
[TBL] [Abstract][Full Text] [Related]
18. Effective meglumine antimoniate intralesional therapy for Chiclero's ulcer refractory to systemic liposomal amphotericin B.
Spinicci M; Zammarchi L; Gramiccia M; Di Muccio T; Bartolozzi D; Corsi P; Trotta M; Bartoloni A
J Travel Med; 2021 Aug; 28(6):. PubMed ID: 32918547
[No Abstract] [Full Text] [Related]
19. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
Moosavi Z; Nakhli A; Rassaii S
Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
[No Abstract] [Full Text] [Related]
20. Comparison Of Efficacy Of Miltefosine Versus Meglumine Antimonate In The Treatment Of Cutaneous Leishmaniasis.
Mohammad N; Sagheer F; Paracha MM; Khan AQ; Naseem S; Wasim M
J Ayub Med Coll Abbottabad; 2022; 34(4):849-853. PubMed ID: 36566412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
